FDA Approves Sanofi’s Meningococcal Vaccine By Sam | April 23, 2020 MenQuadfi will be available in a ready-to-use liquid formulation to allow healthcare providers to avoid vaccine reconstitution. Source: Devices & Diagnostics Letter Posted in Devices & Diagnostics Letter